Journal of Neuro-Oncology 15: 285-287, 1993. Contents Vol. 15 (1993) CONTENTS Vol. 15, No. 1, 1993 Laboratory Investigation Sensitization of C6 glioma cells to radiation by staurosporine, a potent protein kinase C inhibitor W. Zhang, H. Yamada, N. Sakai and Y. Nozawa Clinical Studies Pilot study of 6 weeks of chemoradiotherapy with 5 FU and hydroxyurea in malignant gliomas F.B. Cvitkovic, C. Haie-Meder, V. Papadimitrakopoulou, J.P. Armand, C. Cioloca, N. Maugis and J.P. Constans Phase II study of lonidamine plus radiotherapy in the treatment of brain metastases D.J. Stewart, L. Eapen, A. Girard, S. Verma, P. Genest and W.K. Evans Long term effects of vincristine on the peripheral nervous system T.J. Postma, B.A. Benard, P.C. Huijgens, G.J. Ossenkoppele and J.J. Heimans Aggressive oligodendroglioma predicted by chromosome 10 restriction fragment length polymorphism analysis. Case study J.K. Wu, R.D. Folkerth, Z. Ye and B.T. Darras Schwannoma of the fourth ventricle presenting with hemifacial spasm. A report of two cases H.L. Weiner, D. Zagzag, R. Babu, H.J. Weinreb and J. Ransohoff Diffuse primary leptomeningeal gliomatosis G. Davila, C. Duyckaerts, J.P. Lazareth, M. Poisson and J.Y. Delattre Neurofibromatosis and optic pathways gliomas E.M. Housepian and T.L. Chi Acute changes in glucose uptake after treatment: the effects of carmustine (BCNU) on human glioblastoma multiforme J.M. Rozental, J.D. Cohen, M.P. Mehta, R.L. Levine, J.M. Hanson and R.J. Nickles The transdural extension of gliomas A. Pompili, F. Calvosa, F. Caroli, R. Mastrostefano, E. Occhipinti, L. Raus and F. Sciarretta A phase II evaluation of tamoxifen in unresectable or refractory meningiomas: a Southwest Oncology Group study J.W. Goodwin, J. Crowley, H.J. Eyre, B. Stafford, K.A. Jaeckle and J.J. Townsend Delivery of a novel nitrosourea, MCNU, to the brain tissue in glioma-bearing rats. Intracarotid versus intravenous infusion A. Hodozuka, K. Sako, H. Nakai, M. Tomabechi, N. Suzuki and Y. Yonemasu Solitary brain metastasis 13 years after removal of renal adenocarcinoma M. Ammirati, M. Samii, G. Skaf and A. Sephernia Letter to the Editor In vitro radiosensitivity of human medulloblastoma cell lines T.J. McMillan Announcements Instructions for authors 286 CONTENTS Vol. 15, No. 2, 1993 Laboratory Investigations Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma C.A. Kruse, D.H. Mitchell, B.K. Kleinschmidt-DeMasters, D. Bellgrau, J.M. Eule, J.R. Parra, Q. Kong and K.O. Lillehei Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model C. Liu, B.F. Kimler, R.G. Evans and R.A. Morantz Clinical Studies Intracranial ependymoma long term outcome, patterns of failure J.J. Kovalic, N. Flaris, P.W. Grigsby, M. Pirkowski, J.R. Simpson and K.A. Roth Recurrent brainstem gliomas treated with oral VP-16 M.C. Chamberlain Therapy of recurrent high grade gliomas with surgery, and autologous mitogen activated IL-2 stimulated killer (MAK) Lymphocytes: I. Enhancement of MAK lytic activity and cytokine production by PHA and clinical use of PHA E.W.B. Jeffes, Il, Y.B. Beamer, S. Jacques, R.S. Silberman, B. Vayuvegula, S. Gupta, J.S. Coss, R.S. Yamamoto and G.A. Granger Neonatal medulloblastoma T. Kayama, T. Yoshimoto, H. Shimizu and Y. Sakurai Brain metastases in breast cancer; natural history, prognostic factors and outcome W. Boogerd, V.W. Vos, A.A.M. Hart and G. Baris Phase II study of tiazofurin in gliomas in adults. A National Cancer Institute of Canada study D.J. Stewart, E. Eisenhauer, D.R. Macdonald, J.G. Cairncross and A. Langleben Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group study S.A. Taylor, J. Crowley, J. Townsend, F.S. Vogel, H. Eyre, J.J. Braun and J.W. Goodwin Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors Y. Iwadate, H. Namba, T. Saegusa and K. Sueyoshi Instructions for authors CONTENTS Vol. 15, No. 3, 1993 Laboratory Investigations Responses of human glioblastoma cells to human natural tumor necrosis factor-a: susceptibility, mechanism of resistance and cytokine production studies S. Sakuma, Y. Sawamura, M. Tada, T. Aida, H. Abe, K. Suzuki and N. Taniguchi BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme J.R. Shapiro, S.A.D. Ebrahim, A.N. Mohamed, P.-Y. Pu and W.R. Shapiro (14C-Methyl)-L-methionine uptake in rat brain tumors before and after treatment with the protein synthesis inhibitor cycloheximide K. Mineura, T. Sasajima, N. Kuwahara, M. Kowada, M. Murakami and K. Uemura Treatment of spinal epidural neuroblastoma xenografts in rats using anti-GD2 monoclonal antibody 3F8 I. Bergman, E. Arbit, M. Rosenblum, S.M. Larson, G. Heller and N.-K. V. Cheung Intracellular growth factor metabolism in proliferation of a brain tumor cell line. Intracellular growth factors and brain tumor proliferation H.T. Whelan, C. Przybylski, D.M. Bajic and M.H. Schmidt Clinical Studies Intracranial myxopapillary ependymoma: case report RE. Warnick, J. Raisanen, B.T. Adornato, M.D. Prados, R.L. Davis, D.A. Larson and P.H. Gutin Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas H.B. Newton, J. Bromberg, L. Junck, M.A. Page and H.S. Greenberg Delayed neurotoxicity of intraventricular interleukin-2: a case report C.A. Meyers and W.K.A. Yung Methotrexate induced brain necrosis and severe leukoencephalopathy due to disconnection of an Ommaya device R. de Waal, P.R. Algra, J.J. Heimans, J.G. Wolbers and P. Scheltens Primary diffuse leptomeningeal gliomatosis (PDLG): a neoplastic cause of chronic meningitis P.-Y. Dietrich, M.S. Aapro, A. Rieder and G.P. Pizzolato Volume Contents Instructions for authors